Beyfortus (RSV injection) Update #2 - Will Not Be Available for the 2023-2024 RSV Season

Dear Marblehead Families,

We regret to inform you that the Beyfortus RSV injection will not be available for the 2023-2024 RSV season at our office.

Shortly after the injection was supposed to be supplied to medical offices, we were notified of a delay in delivery due to supply chain shortages for Beyfortus. Subsequently, both the CDC announced (click here) and manufacturers announced (click here) rationing of Beyfortus. The MA VFC program has specifically notified us that, “[The] ordering shutdown will continue thru the end of this RSV season and sites will not be able to request any doses. Doses will be allocated to birthing hospitals across the state.”

Facing criticism for the supply shortfall, Sanofi noted it had encountered “higher than anticipated demand” and said it had an “aggressive supply plan” in place to exceed past performance of pediatric vaccine launches.

AstraZeneca also noted that demand for Beyfortus had “far surpassed any previous standard.”

In a recent letter, United States Senators requested detailed information on the situation, along with measures to ensure equitable distribution and prevent future shortages.

Marblehead Pediatrics

The information provided herein is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. Always consult your physician or healthcare provider prior to starting any new treatment or with any questions you may have regarding a medical condition.